Interactions of cyclic adenosine monophosphate, brain-derived neurotrophic factor, and glial cell line-derived neurotrophic factor treatment on the survival and growth of postnatal mesencephalic dopamine neurons in vitro

Experimental Neurology

Volumn 180, Issue 1, 2003, Pages 32-45

  Lara, Jesus ^a,b,c   Kusano, Kiyoshi ^a   House, Shirley ^a   Gainer, Harold ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b UNIVERSIDAD DE COLIMA   (Mexico)

^c Building 36 ^*  (Mexico)

Author keywords

BDNF; CAMP; Dopaminergic neurons; GDNF; MAP kinase; Mesencephalon; Parkinson's disease; Substantia nigra; Tyrosine hydroxylase

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ANTIBODY; BRAIN DERIVED NEUROTROPHIC FACTOR; BUCLADESINE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; FORSKOLIN; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GROWTH FACTOR; ISOBUTYLMETHYLXANTHINE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; NEUROTROPHIN; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; CULTURE MEDIUM; DOPAMINERGIC NERVE CELL; DRUG EFFECT; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; NERVE CELL CULTURE; NERVE CELL GROWTH; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RAT;

EID: 0037351557     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-4886(02)00028-6     Document Type: Article

References (75)

1. Airaksinen M.S., Titievsky A., Saarma M. GDNF family neurotrophic factor signaling four masters, one servant? Mol. Cell Neurosci. 13:1999;313-325.
2. Alexi T., Borlongan C.V., Faull R.L.M., Williams C.E., Clark R.G., Gluckman P.D., Hughes P.E. Neuroprotective strategies for basal ganglia degeneration Parkinson's and Huntington's diseases . Prog. Neurobiol. 60:2000;409-470.
3. Baloh R.H., Enomoto H., Johnson E.M. Jr., Milbrandt J. The GDNF family ligands and receptors - Implications for neural development. Curr. Opin. Neurobiol. 10:2000;103-110.
4. Beck K.D., Valverde J., Alexi T., Poulsen K., Moffat B., Vandlen R.A., Rosenthal A., Hefti A. GDNF protects mesencephalic dopaminergic neurons from axotomy-induced degeneration in the adult brain. Nature. 373:1995;339-341.
5. Berridge M.V., Tan A.S., Hilton C.J. Cyclic adenosine monophosphate promotes cell survival and retards apoptosis in a factor-dependent bone marrow-derived cell line. Exp. Hematol. 21:1993;269-276.
6. Björklund A., Rosenblad C., Winkler C., Kirik D. Studies on neuroprotective and regenerative effects of GDNF in a partial lesion model of Parkinson's disease. Neurobiol. Dis. 4:1997;186-200.
7. Bonni A., Brunet A., West A.E., Datta S.R., Takasu M.A., Greenberg M.E. Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms. Science. 286:1999;1358-1362.
8. Bornfeldt K.E., Krebs E.G. Crosstalk between protein kinase A and growth factor receptor signaling pathways in arterial smooth muscle. Cell Signal. 11:1999;465-477.
9. Bowenkamp K.E., Hoffman A.F., Gerhardt G.A., Henry M.A., Biddle P.T., Hoffer B.J., Granholm A.E. Glial cell line-derived neurotrophic factor supports survival of injured midbrain dopaminergic neurons. J. Comp. Neurol. 355:1995;479-489.
10. Branton R.L., Love R.M., Clarke D.J. cAMP included during cell suspension preparation improves survival of dopaminergic neurons in vitro. NeuroReport. 9:1998;3223-3227.
11. Brewer J., Torricelli J.R., Evege E.K., Price P.J. Optimized survival of hippocampal neurons in B27-supplemented Neurobasal, a new serum-free medium combination. J. Neurosci. Res. 35:1993;567-576.
12. Burke R.E., Antonelli M., Sulzer D. Glial cell line-derived neurotrophic growth factor inhibits apoptotic death of postnatal substantia nigra dopamine neurons in primary culture. J. Neurochem. 71:1998;517-525.
13. Cardozo D.L. Midbrain dopaminergic neurons from postnatal rat in long-term primary culture. Neuroscience. 56:1993;409-421.
14. Chang L., Karin M. Mammalian MAP kinase signaling cascades. Nature. 410:2001;37-40.
15. Choi-Lundberg D.L., Lin Q., Chang Y.-N., Chiang Y.L., Hay C.M., Mohajeri H., Davidson B.L., Bohn M.C. Dopaminergic neurons protected from degeneration by GDNF gene therapy. Science. 275:1997;838-841.
16. Clarkson E.D., Zawada W.M., Freed C.R. GDNF reduces apoptosis in dopaminergic neurons in vitro. NeuroReport. 7:1995;145-149.
17. Collier T.J., Sortwell C.E. Therapeutic potential of nerve growth factors in Parkinson's disease. Drugs Aging. 14:1999;261-287.
18. Du X., Iacovetti L. Synergy between growth factors and transmitters required for catecholamine differentiation in brain neurons. J. Neurosci. 15:1995;5420-5427.
19. Dunnett S.B., Björklund A. Prospects for new restorative and neuroprotective treatments in Parkinson's disease. Nature. 399:1999;A32-A39.
20. Engele J., Franke B. Effects of glial cell line-derived neurotrophic factor (GDNF) on dopaminergic neurons require concurrent activation of cAMP-dependent signaling pathways. Cell Tissue Res. 286:1996;235-240.
21. Erickson J.T., Brosenstsch T.A., Katz D.M. Brain-derived neurotrophic factor and glial line-derived neurotrophic factor are required simultaneously for survival of dopaminergic primary sensory neurones in vivo. J. Neurosci. 21:2001;581-589.
22. Feng L., Wang C.Y., Jiang H., Oho C., Dugich-Djordjevic M., Mei L., Lu B. Differential signaling of glial cell line-derived neurotrophic factor and brain-derived neurotrophic factor in cultured ventral mesencephalic neurons. Neuroscience. 93:1999;265-273.
23. Finkbeiner S. CREB couples neurotrophin signals to survival messages. Neuron. 25:2000;11-14.
24. Franke B., Bayatti N., Engele J. Neurotrophins require distinct extracellular signals to promote the survival of CNS neurons in vitro. Exp. Neurol. 165:2000;125-135.
25. Gash D.M., Zhang Z., Gerhardt G. Neuroprotective and neurorestorative properties of GDNF. Ann. Neurol. 44:1998;S121-S125.
26. Goldberg J.L., Barres B.A. The relationship between neuronal survival and regeneration. Annu. Rev. Neurosci. 23:2000;579-612.
27. Hanson M.G. Jr., Shen S., Wiemelt A.P., McMorris F.A., Barres B.A. Cyclic AMP elevation is sufficient to promote the survival of spinal motor neurons in vitro. J. Neurosci. 18:1998;7361-7371.
28. Harada H., Becknell B., Wilm M., Mann M., Huang L.J.-S., Taylor S.S., Scott J.D., Korsmeyer S.J. Phosphorylation and inactivation of BAD by mitochondria-anchored protein kinase A. Mol. Cell. 3:1999;413-422.
29. +-induced degeneration. J. Neurosci. Res. 32:1992;190-201.
30. Hyman C., Hofer M., Barde Y.A., Juhasz M., Yancopoulos G.D., Squinto S.P., Lindsay R.M. BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature. 350:1991;230-232.
31. Hyman C., Juhasz M., Jackson C., Wright P., Ip N.Y., Lindsay R.M. Overlapping and distinct actions of the neurotrophins BDNF, NT-3, NT-4/5, on cultured dopaminergic and GABAergic neurons of the ventral mesencephalon. J. Neurosci. 14:1994;335-347.
32. Jing S., Wen D., Yu Y., Holst P.L., Luo Y., Fan M., Tamir R., Antonio L., Hu Z., Cupples R., Louis J.C., Hu S., Altrock B.W., Fox G.M. GDNF-induced activation of the Ret protein tyrosine kinase is mediated by GDNFR-α, a novel receptor for GDNF. Cell. 85:1996;1113-1124.
33. Jing S., Yu Y., Fanf M., Hu Z., Holst P.L., Boone T., Delaney J., Schultz H., Zhou R., Fox G.M. GFR α-2 and GFR α-3 are two new receptors for ligands of the GDNF family. J. Biol. Chem. 272:1997;33111-33117.
34. Knusel B., Winslow J.W., Rosenthal A., Burton L.E., Seid D.P., Nikolics K., Hefti F. Promotion of central cholinergic and dopaminergic neuron differentiation by brain-derived neurotrophic factor but not neurotrophin 3. Proc. Natl. Acad. Sci. USA. 88:1991;961-965.
35. Kordower J.H., Emborg M.E., Bloch J., Ma S.Y., Chu Y., Leventhal L., McBride J., Chen E.Y., Palfi S., Roitberg B.Z., Brown W.D., Holden J.E., Pyzalski R., Taylor M.D., Carvey P., Ling Z., Trono D., Hatraye P., Deglon N., Aebisher P. Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate model of Parkinson's disease. Science. 290:2000;767-772.
36. Lewin G.R., Barde Y. Physiology of the neurotrophins. Annu. Rev. Neurosci. 19:1996;289-317.
37. Lin L.-F.H., Doherty D.H., Lile J.D., Bektesh S., Collins F. GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science. 260:1993;1130-1132.
38. Marsh H.N., Scholz W.K., Lamballe F., Klein R., Nanduri V., Barbacid M., Palfrey H.C. Signal transduction events mediated by the BDNF receptor gp145trkB in primary hippocampal pyramidal cell culture. J. Neurosci. 13:1993;4281-4292.
39. Masuko S., Nakajima S., Nakajima Y. Dissociated high-purity dopaminergic neuron cultures from the substantia nigra and the ventral tegmental area of the postnatal rat. Neuroscience. 49:1992;347-364.
40. Matsuo A., Nakamura S., Akiguchi I. Immunohistochemical localization of glial cell line-derived neurotrophic factor family receptor α-1 in the rat brain confirmation of expression in various neuronal systems . Brain Res. 859:2000;57-71.
41. Merlio J.-P., Ernfors P., Jaber M., Persson H. Molecular cloning of rat trkC and distribution of cells expressing messenger RNAs for members of the trk family in the rat central nervous system. Neuroscience. 51:1992;513-532.
42. Meyer-Franke A., Kaplan M.R., Pfrieger F.W., Barres B.A. Characterization of the signaling interactions that promote the survival and growth of developing retinal ganglion cells in culture. Neuron. 15:1995;805-819.
43. Meyer-Franke A., Wilkinson G.A., Kruttgen A., Hu M., Munro E., Hanson M.G. Jr., Reichardt L.F., Barres B.A. Depolarization and cAMP elevation rapidly recruit TrkB to the plasma membrane of CNS neurons. Neuron. 21:1998;681-693.
44. Michel P.P., Agid Y. Chronic activation of the cyclic AMP signaling pathway promotes development and long-term survival of mesencephalic dopaminergic neurons. J. Neurochem. 67:1996;1633-1642.
45. Nosrat C.A., Tomac A., Hoffer B.J., Olson L. Cellular and developmental patterns of expression of Ret and glial line-derived neurotrophic factor receptor alpha mRNAs. Exp. Brain Res. 115:1997;410-422.
46. Ogilvie J.M., Speck J.D., Lett J.M. Growth factors in combination, but not individually, rescue rd mouse photoreceptors in organ culture. Exp. Neurol. 161:2000;676-685.
47. Oo T.F., Burke R.E. The time course of developmental cell death in phenotypically defined dopaminergic neurons of the substantia nigra. Dev. Brain Res. 98:1997;191-196.
48. Pochon N.A.-M., Menoud A., Tseng J.L., Zurn A.D., Aebischer P. Neuronal GDNF expression in the adult rat nervous system identified by in situ hybridization. Eur. J. Neurosci. 9:1997;463-471.
49. Rayport S., Sulzer D., Shi W.-X., Sawasdikosol S., Monaco J., Batson D., Rajendran G. Identified postnatal mesolimbic dopamine neurons in culture morphology and electrophysiology . J. Neurosci. 12:1992;4264-4280.
50. Riccio A., Ahn S., Davenport C.M., Blendy J.A., Ginty D.D. Mediation by a CREB family transcription factor of NGF-dependent survival of sympathetic neurons. Science. 286:1999;2358-2361.
51. Richards J.S. New signaling pathways for hormones and cyclic adenosine 3′,5′-monophosphate action in endocrine cells. Mol. Endocrinol. 15:2001;209-218.
52. Sauer H., Rosenblad C., Björklund A. Glial cell line-derived neurotrophic factor but not transforming growth factor 3 prevents delayed degeneration of nigral dopaminergic neurons following striatal 6-hydroxydopamine lesion. Proc. Natl. Acad. USA. 92:1995;8935-8939.
53. Sautter J., Meyer M., Spenger C., Seiler R.W., Widmer H.R. Effects of combined BDNF and GDNF treatment on cultured dopaminergic midbrain neurons. NeuroReport. 9:1998;1093-1096.
54. Schatz D.S., Kaufmann W.A., Saria A., Humpel C. Dopamine neurons in a simple GDNF-treated meso-striatal organotypic co-culture model. Exp. Brain Res. 127:1999;270-278.
55. Seroogy K.B., Gall C.M. Expression of neurotrophins by midbrain dopaminergic neurons. Exp. Neurol. 124:1993;119-128.
56. Shaywitz A.J., Greenberg M.E. CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals. Annu. Rev. Biochem. 68:1999;821-861.
57. Shen S., Wiemelt A.P., McMorris F.A., Barres B.A. Retinal ganglion cells lose trophic responsiveness after axotomy. Neuron. 23:1999;285-295.
58. Shults C.W., Kimber T., Altar C.A. BDNF attenuates the effects of intrastriatal injection of 6-hydroxydopamine. NeuroReport. 6:1995;1109-1112.
59. Sinclair S.R., Svendsen C.N., Torres E.M., Martin D., Fawcett J.W., Dunett S.B. GDNF enhances dopaminergic cell survival and fibre outgrowth in embryonic nigral grafts. NeuroReport. 7:1996;2547-2552.
60. Studer L., Spenger C., Seiler J.R.W., Altar C.A., Lindsay R.M., Hyman C. Comparison of the effects of the neurotrophins on the morphological structure of dopaminergic neurons in cultures of rat substantia nigra. Eur. J. Neurosci. 7:1995;223-233.
61. Takahashi M., Buma Y., Imoto T., Inaguma Y., Ikeda H., Hiai H. Cloning and expression of the ret proto-oncogene encoding a tyrosine kinase with two potential transmembrane domains. Oncogene. 3:1988;571-578.
62. Tomac A., Lindquist E., Lin L.F., Ogren D., Young D., Hoffer B.J., Olson L. Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature. 373:1995;335-339.
63. Treanor J.J.S., Goodman L., de Sauvage F., Stone D.M., Poulsen K.T., Beck C.D., Gray C., Pollock R.A., Hefti F., Philips H., Goddard S., Moore M.W., Buj-Bello A., Davies A.M., Asai N., Takahashi M., Vandlen R., Henderson C.E., Rosenthal A. Characterization of a multicomponent receptor for GDNF. Nature. 382:1996;80-83.
64. Trupp M., Arenas E., Fainzilber M., Nilsson A.-S., Sieber B.-A., Grigorior M., Kilkenny C., Salazar-Grueso E., Pachnis V., Arumae U., Sariola H., Saarma M., Ibanez C.F. Functional receptor for GDNF encoded by the c-ret proto-oncogene. Nature. 381:1996;785-789.
65. Trupp M., Belluardo N., Funakoshi H., Ibanez C.F. Complementary and overlapping expression of glial cell line-derived neurotrophic factor (GDNF), c-ret proto-oncogene, and GDNF receptor-α indicates multiple mechanisms of trophic actions in the adult rat CNS. J. Neurosci. 17:1997;3554-3567.
66. Trupp M., Scott R., Whittemore S.R., Ibanez C.F. Ret-dependent and independent mechanisms of glial cell line-derived neurotrophic factor signaling in neuronal cells. J. Biol. Chem. 274:1999;20885-20894.
67. Tsukahara T., Takeda M., Shimohama S., Ohara O., Hashimoto N. Effects of brain-derived neurotrophic factor on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in monkeys. Neurosurgery. 37:1995;733-739.
68. Unsicker K. Growth factors in Parkinson's disease. Progress Growth Factor Res. 5:1994;73-87.
69. Unsicker K., Krieglstein K. Co-activation of TGF-ss and cytokine signaling pathways are required for neurotrophic functions. Cytokine Growth Factor Rev. 11:2000;97-102.
70. van Weering D.H., Bos J.L. Signal transduction by the receptor tyrosine kinase. Ret. Recent Results Cancer Res. 154:1998;271-281.
71. Vossler M.R., Yao H., York R.D., Pan M.-G., Rim C.S., Stork P.J.S. cAMP activates MAP kinase and Elk-1 through a B-Raf- and Rap1-dependent pathway. Cell. 89:1997;73-82.
72. Walton M.R., Dragunow I. Is CREB a key to neuronal survival? Trends Neurosci. 23:2000;48-53.
73. Worby C.A., Vega Q.C., Zhao Y., Chao H.H.-J., Seasholtz A.F., Dixon J.E. Glial cell line derived neurotrophic factor signals through the RET receptor and activates mitogen-activated protein kinase. J. Biol. Chem. 271:1996;23619-23622.
74. Yan Q., Wang J., Matheson C.R., Urich J.L. Glial cell line-derived neurotrophic factor (GDNF) promotes the survival of axotomized retinal ganglion cells in adult rats comparison to and combination with brain-derived neurotrophic factor (BDNF) . J. Neurobiol. 38:1999;382-390.
75. Zurn A.D., Winkel L., Menoud A., Djabali K., Aebischer P. Combined effects of GDNF, BDNF, and CNTF on motoneuron differentiation in vitro. J. Neurosci. Res. 44:1996;133-141.